Search result for 'visual impairment'

IAMAI raises concerns about the high compliance costs of draft accessibility norms for OTT platforms, potentially impacting smaller players.

Biocon Biologics receives Health Canada approval for its biosimilar Yesafili injection, used to treat various eye ailments. Launch is scheduled for July 4, 2025.

Sebi directs market intermediaries to extend digital KYC services to persons with disabilities, issuing FAQs for account opening and ensuring accessibility standards.

Biocon Biologics has secured market entry for its biosimilar product Yesafili in the US after reaching a settlement agreement with Regeneron. Yesafili, a biosimilar of Eylea (aflibercept), will be...

EY India partners with National Association for the Blind (NAB) to create over 600 audiobooks for visually impaired people across India. The initiative aims to empower differently-abled individuals.

Star Health introduces Special Care Gold, the first insurance policy in Braille, designed for individuals with 40% or more disability. This initiative promotes inclusivity and accessibility in...

Punjab National Bank introduces a Braille Debit Card for visually impaired customers, promoting inclusivity and financial accessibility.

Biocon Biologics has received USFDA approval for Yesafili, a biosimilar to Eylea (aflibercept), for treating various ophthalmology conditions like age-related macular degeneration.

Urban Company has updated its app to be accessible for visually impaired users, featuring voiceover and talkback integration for a seamless experience.